92403-21-9 Usage
Description
1-(2,3-dihydro-1H-inden-2-yl)hydrazine hydrochloride is a chemical compound that features a hydrazine group connected to a 1H-inden-2-yl moiety, existing as a hydrochloride salt. It is recognized for its potential applications in organic synthesis and pharmaceutical research, where it serves as a valuable reagent and intermediate. 1-(2,3-dihydro-1H-inden-2-yl)hydrazine hydrochloride also exhibits possible biological activities, which makes it a promising candidate for drug development. However, it is crucial to handle this compound with caution due to its potentially hazardous nature, and it should only be utilized by trained professionals within controlled laboratory environments.
Uses
Used in Organic Synthesis:
1-(2,3-dihydro-1H-inden-2-yl)hydrazine hydrochloride is used as a reagent in organic synthesis for its ability to facilitate various chemical reactions and contribute to the formation of complex molecular structures.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(2,3-dihydro-1H-inden-2-yl)hydrazine hydrochloride is used as an intermediate in the development of new drugs, leveraging its potential biological activities and chemical properties to create novel therapeutic agents.
Used in Drug Development:
Due to its potential biological activities, 1-(2,3-dihydro-1H-inden-2-yl)hydrazine hydrochloride is also utilized in drug development as a compound of interest that may lead to the creation of new medications for various health conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 92403-21-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,4,0 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 92403-21:
(7*9)+(6*2)+(5*4)+(4*0)+(3*3)+(2*2)+(1*1)=109
109 % 10 = 9
So 92403-21-9 is a valid CAS Registry Number.
92403-21-9Relevant articles and documents
COMPOUNDS USEFUL AS KINASE INHIBITORS
-
Paragraph 00312, (2017/07/14)
This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK).The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.
